Skip to main content
. 2021 Jul 5;2021(7):CD011301. doi: 10.1002/14651858.CD011301.pub2

Comparison 50. IncobotulinumtoxinA 54 to 64units versus placebo one cycles of treatment glabellar lines, forehead liens, crow's feet lines.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
50.1 Any major adverse events (eyelid ptosis, eyelid sensory disorder, strabismus) 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
50.2 Physician assessment of success by analysing scores and scales 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
50.2.1 4 weeks‐ Glabella 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
50.2.2 4 weeks ‐ forehead 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
50.2.3 4 weeks crow's feet line 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
50.3 Total adverse events 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected